immunotherapy

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

immunotherapy
Jun 14, 2024, 15:14 | Blog
Marco Davila: Great news from Society for Immunotherapy of Cancer for this years meeting in Houston
Marco Davila, Senior Vice President of Translational Research at Roswell Park Comprehensive Cancer Center, shared…
Jun 14, 2024, 09:12 | Blog
CRI: "Immunotherapy prior to surgery could well become a game-changer" - Mark Saunders
Cancer Research Institute (CRI) shared on LinkedIn:       . "According to clinical trial results…
Jun 13, 2024, 17:33 | Insight
Agenus' Phase 1 clinical trial results have been published in Nature
Agenus shared their publication on investigational immunotherapeutic agents in Nature: "Results from our Phase 1…
Jun 13, 2024, 07:54 | Blog
Connect to the ESMO Virtual Plenary to stay up to date with the latest in immunotherapy
ESMO shared on LinkedIn: "What are the early safety and activity profiles of a first-in-class PD-1/IL-2…
Jun 12, 2024, 06:29 | Insight
Neuroendocrine tumors may respond better to an oncolytic virus plus immunotherapy - Sylvester Comprehensive Cancer Center
Sylvester Comprehensive Cancer Center shared on X: "Our researchers, first author, Samuel Kareff and senior…
Jun 12, 2024, 03:30 | Blog
Rasha Aboelhassan: Solving debates for the treatment of stage III inoperable lung cancer is challenging
Rasha Aboelhassan shared on LinkedIn: "For decades, solving debates for the treatment of stage III…
Jun 11, 2024, 01:42 | Blog
Cancer Research Institute's 2024 Spanish-Language Immunotherapy Patient Summit
Quoting Cancer Research Institute (CRI) on LinkedIn: "Featuring Spanish-speaking patients and medical experts, including Dr. Eduardo M.…
Jun 10, 2024, 15:00 | Blog
Sumanta K. Pal: PIVOT09 comparing pegylated IL2/nivolumab to TKI by Nizar Tannir et al.
Sumanta K. Pal shared a post on X: “Huge congrats to Nizar Tannir, MD Anderson Cancer…
Jun 10, 2024, 11:22 | Blog
Angelo Pirozzi: Outstanding works from my colleagues and rising stars Rita Balsano and Giulia Tesini
Angelo Pirozzi, Research Fellow at Mayo Clinic, shared a post on X/Twitter: ''Outstanding works from my…
Jun 10, 2024, 05:09 | Insight
Saurabh Zanwar: Impact of Extramedullary Multiple Myeloma on Outcomes with Ide-cel
Saurabh Zanwar, Assistant Professor at Mayo Clinic, shared on X: “Out now in Journal of…
Jun 10, 2024, 04:49 | Blog
Ibrahim Halil Sahin: I discussed the findings of neoadjuvant rectal cancer study of Dostarlimab with Alison Kanski
Ibrahim Halil Sahin Assistant Professor of Medicine Division of Hematology/Oncology at University of Pittsburgh School of…
Jun 9, 2024, 09:45 | Societies
Chandler Park: A fun discussion at ASCO24 with David O’Malley
Chandler Park recently shared on X: "Dr. David O’Malley and I have a fun discussion…
Jun 8, 2024, 06:52 | Blog
Gabriela Burgos: My key takeaways from ASCO 2024
Gabriela Burgos, Associate Research Director- Evidence Generation Lead, RWE at Oracle shared a post on LinkedIn:…
Jun 7, 2024, 14:37 | Immune Oncology
Immunotherapy for Colorectal Cancer
How immunotherapy works for colorectal cancer Immunotherapy is a revolutionary approach to cancer treatment that…
Jun 6, 2024, 14:05 | Immune Oncology
Immunotherapy for Kidney Cancer
Introduction Kidney cancer, also known as renal cell carcinoma (RCC), is a type of cancer…
Jun 6, 2024, 12:42 | Blog
Robert Daly: Thank you for the mentorship and collaboration of the MATCHES Center team
Robert Daly, Assistant Attending Physician at Memorial Sloan Kettering Cancer Center, shared a post by…
Jun 5, 2024, 13:40 | Immune Oncology
Immunotherapy for Ovarian Cancer: A Growing Field
How Immunotherapy Works for Ovarian Cancer Immunotherapy represents a paradigm shift in the treatment of…
Jun 3, 2024, 03:32 | Blog
Join Jill O'Donnell-Tormey, in kicking off the 12th annual Cancer Immunotherapy Month - Cancer Research Institute
Cancer Research Institute shared on LinkedIn: "Join the Cancer Research Institute's CEO and Director of…
Jun 2, 2024, 23:47 | Insight
NADINA is one of the 11 clinical studies with the biggest impact on health care in 2024 - Netherlands Cancer Institute
Quoting The Netherlands Cancer Institute on LinkedIn: "The NADINA study, led by researchers from the…
Jun 2, 2024, 08:59 | Insight
Ahmad Tarhini: Immune cell state atlas that allows us to resolve complex immune architectures within the TME
Ahmad Tarhini, Director of Cutaneous Clinical and Translational Research at Moffitt Cancer Center, shared on…
Jun 1, 2024, 15:59 | Immune Oncology
Immunotherapy for Lung Cancer
Lung cancer and immunotherapy  Lung cancer is the leading cause of cancer-related deaths worldwide, with…
Jun 1, 2024, 11:46 | Blog
Phase 2 study OptiTROP-Lung01 had promising results in patients with advanced NSCLC - LUNGevity Foundation
LUNGevity Foundation shared on X/Twitter: "Phase 2 study (OptiTROP-Lung01) had promising results in patients with advanced…
Jun 1, 2024, 06:03 | Insight
Florent Petitprez: Hear me talk about biomarkers for immunotherapy in sarcoma at ASCO24
Florent Petitprez, Post-doctoral Research Fellow at The University of Edinburgh, shared on X: “Chicago, here…
Jun 1, 2024, 00:00 | Blog
Tanja Obradovic: Gursel Aktan and Merck women's cancer team on just released positive OS data on KN 522
Tanja Obradovic shared a post on LinkedIn: "Congratulations to amazing leader in immunooncology drug development Gursel…
May 31, 2024, 22:07 | Insight
Ahmad Tarhini: Employing a machine learning framework to molecular data from patients with melanoma
Ahmad Tarhini, Director of Cutaneous Clinical and Translational Research at Moffitt Cancer Center, shared on…
May 31, 2024, 14:27 | Immune Oncology
How Does Immunotherapy Work
What is immunotherapy? Immunotherapy is a type of cancer treatment that uses the power of…
May 31, 2024, 10:52 | Blog
AstraZeneca is one of the industry partners supporting the AACR Clinical Oncology Research (CORE) Training Fellowship
AACR shared a post on LinkedIn: "AstraZeneca is one of the industry partners supporting the AACR…
May 31, 2024, 10:51 | Blog
Yüksel Ürün on CheckMate 901 trial
Yüksel Ürün shared a post on X: "CheckMate 901 trial: Abstract #4509 For lymph node-only mUC,…
May 31, 2024, 10:41 | Blog
Jason A. Mouabbi: Here are my anticipated Top 3 breast cancer presentations for ASCO24
Jason A. Mouabbi, Breast Medical Oncologist at MD Anderson Cancer Center, shared a post on X:…
May 29, 2024, 13:43 | Immune Oncology
Immunotherapy for Cancer: An Overview
What is immunotherapy? Immunotherapy is a type of cancer treatment that helps your own immune…
May 29, 2024, 11:10 | Blog
The future of immunotherapy in melanoma and beyond on the ASCO Daily News Podcast
ASCO made the following post on X: "Diwakar Davar & Jason Luke of UPMC Hillman Cancer…
May 29, 2024, 10:00 | Blog
Jason Luke: Discussing ASCO24 abstracts with Diwakar Davar
Jason Luke, Associate Professor at the University of Pittsburgh, shared a post on X: "Appreciated…
May 29, 2024, 09:54 | Blog
Roberto Pestana: Below are my top-10 sarcoma abstracts to look forward to at ASCO24
Roberto Pestana, Chair of the LACOG sarcoma group, shared a post on X: "ASCO24 is just…
May 28, 2024, 07:57 | Dialogues
Oncothon: Pediatric Oncology with Godfrey Chan, Nita Radhakrishnan
Oncothon is a telethon spanning 24 hours, dedicated to gathering donations for childhood cancer research.…
May 27, 2024, 13:01 | Blog
Miguel Bronchud: Stress and cancer are they really related?
Miguel Bronchud, Co-Founder of Regenerative Medicine Solutions, shared on LinkedIn: ''Stress and cancer- are they…
May 27, 2024, 07:35 | Blog
Check out the state of immunotherapy in resectable NSCLC - FDA Oncology
FDA Oncology shared a post on X: “Check out the state of immunotherapy in resectable NSCLC:…
May 27, 2024, 01:07 | Blog
Discover Pancreatic Cancer Demystified: Expert Insights and Breakthroughs with Robert H. Vonderheide - Cancer Research Institute
Cancer Research Institute (CRI) shared on their LinkedIn: ''Register to discover Pancreatic Cancer Demystified: Expert…
May 26, 2024, 16:38 | Blog
Zouina Sarfraz: Two of my abstracts have been published for the 2024 ASCO Annual Meeting
Zouina Sarfraz, Associate Editor at BMC, shared a post on LinkedIn: "I am pleased to announce…
May 25, 2024, 14:20 | Blog
Marc Machaalani: Immunotherapy rechallenge after prior immune checkpoint inhibition in mRCC
Marc Machaalani, Postdoctoral Research Fellow at Dana-Farber Cancer Institute, shared a post by ASCO on…
May 25, 2024, 11:59 | Blog
Vivek Subbiah: ASCO 24 time to learn the latest and greatest in Tissue Agnostic Precision Medicine
Vivek Subbiah shared on X: “It's ASCO 24 time Mark your calendars to learn the latest…
May 24, 2024, 14:48 | Blog
Humaid Al-Shamsi: Abstracts presented during the WIN Symposium 2024 in Abu Dhabi are now published
Humaid Al-Shamsi, Director of Burjeel Cancer Institute Comprehensive Cancer Center, shared a post on LinkedIn: "Excited…
May 24, 2024, 13:24 | Insight
Erman Akkus Summarizes 5-year Results of CheckMate 040
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X: “Nivolumab plus ipilimumab…
May 23, 2024, 14:25 | Insight
Benjamin Besse: Should we infuse IO in the morning?
Benjamin Besse, Head of Clinical Research on Gustave Roussy, shared on X: "Should we infuse…
May 23, 2024, 14:08 | Blog
Pashtoon Kasi: The largest series to date on POL-E or POLD1 metastatic Colorectal Cancer and the use of immunotherapy
Pashtoon Kasi shared a post on LinkedIn: "The largest series to date on POL-E or POLD1…
May 23, 2024, 13:06 | Drugs
Ajay Major: Outcomes for DLBCL in CR at time of CAR-T infusion from CIBMTR
Ajay Major, Assistant Professor at the University of Colorado School of Medicine, recently shared a…
May 23, 2024, 11:26 | Drugs
Enrique Grande: Cabozantinib with or without PD-1/L1 inhibitors for metastatic clear cell renal cell carcinoma
Enrique Grande, Head of Oncology at MD Anderson Madrid Cancer Center, recently shared a post…
May 23, 2024, 07:56 | Blog
Chinmay Jani: Let's explore EGFR Exon 20 Insertion NSCLC with a twist of Miami flair!
Chinmay Jani, Clinical Fellow, Hematology & Oncology at University of Miami, made the following post…
May 23, 2024, 07:39 | Blog
Daniel Sterman: Congratulations Antonio Velez, on his superb presentation of our NCI-funded clinical trial
Daniel Sterman, Director of Division of Pulmonary, Critical Care, and Sleep Medicine at NYU Langone Health, made…
May 23, 2024, 06:36 | Insight
María Natalia Gandur Quiroga: New insights on immunotherapy rechallenge in mRCC
María Natalia Gandur Quiroga shared on X: "New insights on immunotherapy rechallenge in mRCC! Key…
May 21, 2024, 13:38 | Blog
Dr. Erik Sahai About His Research and Story with the the Metastasis Research Society
Metastasis Research Society shared on X: “Meet the presidents! We asked the current president of…
May 21, 2024, 09:09 | Insight
Luca Licata: How to navigate the practical challenges in immunotherapy for mTNBC
Luca Licata, Medical Oncologist at Breast Cancer Group - San Raffaele Scientific Institute, shared on…
May 20, 2024, 15:44 | Blog
David Seo: Thank you to Evan Hall and Dr. Byrd for the opportunity to present the work going on in the Jennifer Wargo lab
David Seo, Fellow in Surgical Oncology MD Anderson Cancer Center, shared a post by Evan Hall, Assistant…
May 20, 2024, 13:23 | Blog
Cathy Eng: Role for IO therapy in MSS with Dr. Neil Segal and Dr. Michael Overman
Cathy Eng shared on X: “Last debate Great Debates & Updates on Day 1 w Dr.…
May 20, 2024, 12:14 | Blog
Pashtoon Kasi: The surgery could now be the “adjuvant” piece
Pashtoon Kasi shared on LinkedIn: "Here’s a provocative from one of my colleagues: Instead of calling…
May 18, 2024, 09:54 | Societies
Paolo Tarantino: Why was IMpassion132 negative?
Daniel Stover, Medical Oncologist and Computational Biologist at Ohio State University Comprehensive Cancer Center, shared…
May 18, 2024, 06:04 | Blog
Deniz Can Guven: The 1st-in-human phase 1 study on arginase inhibitor INCB001158
Deniz Can Guven, Medical Oncologist at Health Sciences University, Elazığ City Hospital, shared on X/Twitter:…
May 17, 2024, 00:15 | Blog
2024-25 Patient Education Ambassadors Program - Arya Roy
Grace shared on X/Twitter: "Meet Dr. Arya Roy! Dr. Roy actively engages in clinical and…
May 16, 2024, 08:20 | Cancer Types
Neuroblastoma: What patients should know about
What is Neuroblastoma? Neuroblastoma is a type of cancer that originates in early nerve cells,…
May 15, 2024, 12:22 | Blog
The Babak Lab - Exciting Progress in Melanoma Treatment: Personalized Vaccines Show Promise
Maria Babak, Head of Drug Discovery Lab at City University of Hong Kong, shared a post…
May 14, 2024, 16:10 | Blog
Luis E. Raez: Unfortunatly adding IO to chemo/radiation is not working but we have other options
Luis E. Raez, Medical Director of Memorial Cancer Institute, shared a post by Patrick Forde, Co-Director of…
May 14, 2024, 14:59 | Blog
Annals of Oncology March 2024 issue article of the month
Annals of Oncology shared a post by Annals of Oncology on X/Twitter, adding: ''The article…
May 14, 2024, 10:59 | Blog
Vivek Subbiah: Sharing our editorial on Rationalizing rules for immunotherapy combination trials
Vivek Subbiah shared on X: “Sharing our editorial on rationalizing rules for immunotherapy combination trials,…
May 13, 2024, 14:53 | Blog
Ruzanna Papyan: The life-saving potential of anti-GD2 therapy in treating high-risk neuroblastoma
Ruzanna Papyan shared the following on LinkedIn: ''Week 2 of the Global Access To AntiGD2…
May 12, 2024, 13:31 | Blog
Stephen Liu: Update from phase 3 IMscin001 trial JTO and JTO CRR
Stephen Liu, Director of Thoracic Oncology and Developmental Therapeutics at Georgetown University, shared on X/Twitter: “Update from…
May 11, 2024, 13:13 | Insight
6th Emirate's Pediatric Hematology and Oncology Conference in Abu Dhabi - Barcelona Children's Hospital Sant Joan de Déu
Barcelona Children's Hospital Sant Joan de Déu shared on LinkedIn: “Last weekend, our hospital took…
May 11, 2024, 07:07 | Blog
Caitlin Delaney: Yet I am one of the lucky ones - on paper I shouldn't be here
Caitlin Delaney, Chair of the National Patient Advisory Committee, Patient-Partnered Research at VCCC Alliance, shared…
May 10, 2024, 15:58 | Blog
Sunil Verma: Great to be at the Milken Institute Global Conference in Los Angeles!
Sunil Verma, Senior Vice President of Global Head of Oncology at AstraZeneca, shared on LinkedIn: “Great…
May 8, 2024, 23:45 | Blog
Maite Bourlon: 12th Annual Symposium on Global Cancer Research
Maite Bourlon shared on X: “12th Annual Symposium on Global Cancer Research Great to chair this…
May 8, 2024, 13:50 | Opinion
NCI Center for Cancer Research - Alka Dwivedi was honored in this year's list of TIME100 Most Influential in Health
NCI Center for Cancer Research shared a post on LinkedIn: "IN THE NEWS: If you haven't…
May 8, 2024, 07:02 | Insight
Piotr Wysocki: Immunotherapy after chemotherapy may be the right choice
Piotr Wysocki recently shared on LinkedIn: "Mariniello A. et al. published results of an important preclinical…
May 8, 2024, 00:58 | Blog
Stephen V Liu: Dr. Passiglia Fra at Rome Lung 24 illustrates the limited role of immunotherapy in driver positive NSCLC
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Georgetown University at Lombardi…
May 8, 2024, 00:50 | Blog
Stephen V Liu: Dr. Giulia Pasello at Rome Lung 24 discusses duration of immunotherapy for NSCLC
Stephen V Liu, Director of Thoracic Oncology and Developmental Therapeutics at Georgetown University at Lombardi…
May 7, 2024, 10:39 | Blog
Caryn Lerman: Saul Priceman will be the founding director of the new KSOM/USC Norris Center for Cancer Cellular Immunotherapy Research
Caryn Lerman, Research Advocate Training and Support (RATS) Manager at Fight Colorectal Cancer, shared on LinkedIn:…
May 7, 2024, 06:28 | Insight
Elisa Agostinetto: The long and winding road to biomarkers for immunotherapy
Elisa Agostinetto, Clinical Research Fellow at Institute Jules Bordet, shared on LinkedIn: "The long and…
May 6, 2024, 19:10 | Blog
Erman Akkus: ASCO Ed book on mNSCLC without oncogenic alterations
Erman Akkus, medical oncologist at Ankara Medical University, shared on Twitter/X: "Metastatic NSCLC without oncogenic…
May 6, 2024, 09:34 | Insight
Piotr Wysocki: Striking activity of metronomic chemotherapy in a critically advanced cutaneous squamous cell cancer
Piotr Wysocki recently shared on LinkedIn: "In many countries, the availability of checkpoint inhibitors-based immunotherapy is…
May 5, 2024, 23:35 | Blog
Raffaele Giusti: Withholding opioids for pain in immunotherapy patients?
Raffaele Giusti, Medical Oncologist at Sant'Andrea Hospital of Rome, made the following post on LinkedIn:…
May 5, 2024, 14:01 | Blog
Maite Gorostegui: Our paper about Management of High-Risk Neuroblastoma in the Era of Anti-GD2 Immunotherapy
Maite Gorostegui, Pediatric Oncologist at Pediatric Cancer Center Barcelona, shared a post on LinkedIn: "We just…
May 5, 2024, 07:02 | Blog
Francisco J. Esteva: 5 common myths or misconceptions about cancer immunotherapy
Francisco J. Esteva, Chief of Division of Hematology and Medical Oncology, Lenox Hill Hospital, shared a…
May 5, 2024, 00:46 | Insight
Pashtoon Kasi: Why would neoadjuvant immunotherapy work better
Pashtoon Kasi shared a post on LinkedIn: “AWhy would immunotherapy work better when given before…
May 3, 2024, 07:08 | Blog
NCI Center for Cancer Research - Sandra Wolin, Steven Rosenberg, Giorgio Trinchieri from NCI CCR were elected into National Academy of Sciences
NCI Center for Cancer Research shared a post on LinkedIn: "STAFF SPOTLIGHT: We are so honored…
May 2, 2024, 12:01 | Blog
Ramy Sedhom: In lockstep with the ASCO Presidential Theme - Palliative Care is on the stage as a plenary at this year's Annual Meeting
Ramy Sedhom, Clinical Director of Palliative Care at Penn Medicine Princeton Health, shared a post…
May 1, 2024, 21:39 | Blog
It’s the one-two punch cancer treatment that ‘floats like a butterfly, and STINGs like a bee’! - WEHI (Walter and Eliza Hall Institute of Medical Research)
WEHI (Walter and Eliza Hall Institute of Medical Research) made the foll0wing post on LinkedIn:…
May 1, 2024, 19:55 | Career
Harriet Kluger has accepted accepted candidacy for At-Large Director in Society for Immunotherapy of Cancer (SITC) - Yale Cancer Center
Yale Cancer Center shared on their LinkedIn page: “We are pleased to share that Harriet…
May 1, 2024, 06:04 | Insight
Martin Stumpe: Predicting MSI in prostate cancer from hematoxylin and eosin stained biopsy
Martin Stumpe, Chief of AI at Tempus, shared on LinkedIn: “We recently published a paper…
Apr 29, 2024, 15:35 | Blog
Pashtoon Kasi: Time to revise assessment methods to reflect the pattern
Pashtoon Kasi shared a post on X: "Response assessment crudely telling regression % is missing the…
Apr 29, 2024, 15:30 | Insight
Nicola Ferrari: Principles and therapeutic applications of adaptive immunity
Nicola Ferrari, Translational Science Lead at AstraZeneca, made the following post on LinkedIn: "Principles and…
Apr 28, 2024, 01:22 | Blog
Patrick Hwu: Always great to catch up with our incredible founder Lee Moffitt
Patrick Hwu, President and CEO of Moffitt Cancer Center, shared on X: “Always great to catch…
Apr 26, 2024, 18:40 | Blog
Dr. Carl June was awarded the 2024 Break through Prize in Life Sciences for the development of CART cell therapy - Penn Medicine, University of Pennsylvania Health System
Apr 24, 2024, 14:51 | Blog
Jemma Arakelyan: Just completed the ESMO Advanced Course on lung cancer
Jemma Arakelyan, CEO at the Institute of Cancer and Crisis, shared a post on LinkedIn: "Just…
Apr 23, 2024, 20:22 | Blog
Chandler Park: What a FUN precision medicine and immunotherapy meeting at Cleveland Clinic
Chandler Park, Kentucky Physician Representative of the ASCO State Executive Council, shared on LinkedIn: "What a…
Apr 23, 2024, 08:56 | Blog
Naveen Pemmaraju: Appreciated the invitation to speak at MD Education meeting
Naveen Pemmaraju shared a post on X: "Appreciated the invitation to speak at MD Education meeting…
Apr 22, 2024, 20:02 | Blog
Pashtoon Kasi: We underestimate how quickly immunotherapy works
Pashtoon Kasi, Director Colon Cancer Research and Director Precision Medicine Research for Liquid Biopsies at…
Apr 22, 2024, 18:48 | Insight
Piotr Wysocki: Single-agent immunotherapy is a wise choice as first-line treatment in elderly, advanced NSCLC patients, irrespectively of PD-L1 expression
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Apr 22, 2024, 13:35 | Blog
Kipp Weiskopf: Our work on macrophage immunotherapy
Kipp Weiskopf, Valhalla Whitehead Fellow at Whitehead Institute and Co-Founder and Scientific Advisory Board Co-Chair…
Apr 21, 2024, 18:13 | Blog
Antonio Passaro: An intense yet incredibly rewarding day in Oporto
Antonio Passaro, Medical Director with Highly Specialized Position at IEO European Institute of Oncology, shared a…
Apr 19, 2024, 13:53 | Dialogues
Oncothon: Discussion with Professor Eric Small on mentorship and challenges in pediatric cancer treatment
Oncothon is a global telethon spanning 24 hours, dedicated to gathering donations for childhood cancer…
Apr 19, 2024, 06:09 | Blog
Dr. Gilberto Lopes shares about his work in Sylvester Comprehensive Cancer Center
Sylvester Comprehensive Cancer Center shared on LinkedIn: "Gilberto Lopes, associate director of global oncology believes…
Apr 17, 2024, 19:02 | Blog
Katy Beckermann: Exciting update from Dr. Mike Atkins on the novel checkpoint inhibitor LAG3 and its potential role in kidney cancer treatment
Katy Beckermann, Assistant Professor at Vanderbilt University Medical Center, shared a post by GU Oncology…
Apr 17, 2024, 10:09 | Positive
Yaniss B.: The 3rd edition of the Transatlantic Exchanges in Oncology was a huge success!
Yaniss B, Valorisation Officer at Gustave Roussy Transfert shared on X: “The 3rd edition of the…
All: 811 Posts: 601 - 700
Special Coverage